AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Rapid Generation of Retinal Pigmented Epithelium for Retinal Disease Therapy

Technology Benefits

Highly efficient and rapid conversion of human embryonic stem cells to retinal tissue cells A potentially unlimited source of RPE for transplant therapy from human embryonic and induced pluripotent stem cells

Technology Application

Cellular therapy for degenerative retinal diseases Degenerative retinal disease research This technology is available for licensing.

Detailed Technology Description

Researchers at the University of California, Santa Barbara have developed a novel method for rapid and efficient differentiation of human embryonic stem cells into retinal pigmented epithelium. This method yields RPE in the majority of stem cells treated in only half of the time documented for the most efficient methods. The speed and efficiency of the method gives it the potential to significantly advance the fields of research dealing with the causes and therapies for degenerative retinal diseases (e.g. age-related macular degeneration).

Application No.

9458428

Others

Background

Retinal Pigmented Epithelium (RPE) cells can be created from human embryonic and induced pluripotent stem cells. It has been shown, however, that the transformation of these stem cells into RPE is inefficient and very time consuming. Research into degenerative retinal diseases would benefit greatly from a more timely and efficient method for producing RPE from human embryonic stem cells.

Additional Technologies by these Inventors

Methods of Culturing Retinal Pigmented Epithelium Cells

Tech ID/UC Case

22139/2012-019-0

Related Cases

2012-019-0

Country/Region

USA

For more information, please click Here